To compare computed tomography (CT)guided core needle biopsy (CNB) with incisional biopsy in diagnosing musculoskeletal lesions. Methods. 62 men and 50 women aged 12 to 83 (mean, 45) years who underwent a CT-guided CNB were compared with 31 men and 33 women aged 9 to 81 (mean, 53) years who underwent an incisional biopsy. All specimens had final pathology report to compare with. Comparisons were made in terms of (1) diagnostic rate, (2) accuracy in distinguishing benign from malignant lesions, (3) accuracy in distinguishing low-from high-grade sarcomas, (4) accuracy for histological diagnosis, and (5) complication and repeated biopsy rates. results. The diagnostic rate of CT-guided CNB and incisional biopsy was not significantly different (92.9% vs. 96.9%, p=0.33), nor were the accuracy in distinguishing benign from malignant lesions (100% vs. 98.4%, p=0.37), the accuracy in distinguishing low-from high-grade sarcomas (100% vs. 100%, p=1.00), the accuracy for specific diagnosis (75.9% vs. 85.2%, p=0.17), the repeated biopsy rate (6.3% vs. 4.7%, p=0.75), and the complication rate (0.9% vs. 4.7%, p=0.14). The accuracy for specific diagnosis was higher for bone than soft-tissue lesions for both CTguided CNB (87.0% vs. 59.5%, p=0.002) and incisional biopsy (87.0% vs. 77.3%, p=0.43). The accuracy of CT-guided CNB for specific diagnosis of benign softtissue tumours as well as infection and inflammation was relatively low. conclusion. CT-guided CNB is safe, easy to perform, efficient, and less invasive, and should be considered as a first-line biopsy for musculoskeletal lesions.
as seroma, haematoma, infection, wound dehiscence, and tumour contamination, with a rate of up to 16%, and affects 8% of treatment plans. 2, 4 Percutaneous core needle biopsy (CNB) is costeffective and has low complication rates and high accuracy (up to 97%). [5] [6] [7] [8] [9] It is more accurate and safer when performed under computed tomography (CT) guidance, so as to avoid missing the target and injuring neurovascular structures, especially when the lesions are deeply seated and heterogeneous. This study compared computed tomography (CT)-guided core needle biopsy (CNB) with incisional biopsy in diagnosing musculoskeletal lesions.
Materials and Methods
From January 2008 to December 2010, 143 consecutive patients underwent 154 CT-guided CNBs for musculoskeletal lesions. 31 of whom had no final pathology for comparison and were excluded. Biopsies of the remaining 62 men and 50 women aged 12 to 83 (mean, 45) years were compared with those of 31 men and 33 women aged 9 to 81 (mean, 53) years who underwent an incisional biopsy between June 2004 and December 2007 (before introduction of CNB to our hospital). These specimens had final pathology report to compare with.
CT-guided CNB was performed by one of 2 orthopaedic oncologists in conjunction with a radiologist in an out-patient setting for patients with bone and soft-tissue lesions deep to the fascia, heterogeneous on magnetic resonance imaging, or suspected to be malignant. Biopsy principles were strictly adhered so that definitive resection of the tumour was not compromised. The area was prepped and draped and infiltrated for local anaesthesia with 2% lidocaine without adrenalin. A 14-gauge springloaded needle (Supercore; Angiotech, Vancouver, Canada) was used. Six to 10 passes were made through the mass in different directions using single penetration, and cores of tissue were obtained. The number of passes was determined by the orthopaedic oncologists. After taking adequate specimens, the wound was then covered with compressive dressing, and the specimens were immediately fixed in formalin. Each specimen was reviewed by a single pathologist. Special staining and immunohistochemical studies were performed at the discretion of the pathologist. Only sarcoma specimens were graded, and intermediate grade was categorised as high grade.
Comparisons were made in terms of (1) diagnostic rate, (2) accuracy in distinguishing benign from malignant lesions, (3) accuracy in distinguishing low-from high-grade sarcomas, (4) accuracy for histological diagnosis, and (5) complication and repeated biopsy rates.
All incisional biopsies were performed by one of the orthopaedic oncologists under general or spinal anaesthesia in an in-patient setting. The specimens were reviewed by the same pathologist.
Chi-squared test or Fisher's exact test was used as appropriate. Histological pathologies of the biopsies and definitive diagnoses after surgery were compared. A p value of <0.05 was considered statistically significant. 
results
Out of 176 specimens, 34 (19%) were benign bone tumours, 42 (24%) were malignant bone tumours, 11 (6%) were benign soft-tissue tumours, 19 (11%) were malignant soft-tissue tumours, 30 (17%) were bone metastasis and myeloma, and 40 (23%) were infectious/inflammatory lesions (Table 1) .
computed tomography-guided core needle biopsy
Of the 112 specimens obtained by CT-guided CNB, 8 (7.1%) were non-diagnostic, because the specimens contained inadequate tissue (n=1), necrotic tissue only (n=2), and non-specific tissue (n=5) [ Table 2 ]. Among the remaining 104 specimens, distinguishing benign from malignant lesions and low-from highgrade sarcomas was possible. The diagnostic rate of CT-guided CNB was 92.9% (104/112), for which a specific diagnosis was made in 79 (75.9%) of the specimens (Table 3) .
To achieve a diagnosis, 7 (6.3%) of the patients underwent repeated biopsies (4 by CT-guided CNB and 3 by incisional biopsy); 5 were initially non-diagnostic and 2 were initially diagnosed as conventional osteosarcoma and haematoma with an unacceptable level of confidence. None of the biopsy errors resulted in erroneous definitive treatment. All the patients tolerated the procedure well without recourse to any analgesic or sedative medication. One patient developed a small haematoma around the needle scar at the right thigh, and was treated with a wide elliptical skin incision during definitive surgery.
incisional biopsy
Of the 64 specimens obtained by incisional biopsy, 2 (3.1%) were non-diagnostic, because the specimens contained only necrotic tissue (n=1) and non-specific tissue (n=1) [ Table 2 ]. Among the remaining 62 specimens, distinguishing benign from malignant lesions and low-from high-grade sarcomas was possible in 61. One specimen was diagnosed as lipoma but turned out to be a well-differentiated liposarcoma on the final pathology. The diagnostic rate of incisional biopsy was 96.9% (62/64), for which a specific diagnosis was made in 52 (85.2%) of the specimens (Table 3) .
Three (4.7%) of the patients underwent repeated incisional biopsies. Two patients developed wound dehiscence, which was managed by debridement and wound closure, and one patient developed a haematoma, which was treated with a wide elliptical skin incision.
comparison of both biopsy methods
The diagnostic rate of CT-guided CNB and incisional biopsy was not significantly different (92.9% vs. 96.9%, p=0.33), nor were the accuracy in distinguishing benign from malignant lesions (100% Table 3 ].
The accuracy for specific diagnosis was higher for bone than soft-tissue lesions for both CT-guided CNB (87.0% vs. 59.5%, p=0.002) and incisional biopsy (87.0% vs. 77.3%, p=0.43) [ Table 4 ]. The accuracy of both biopsy methods was not significantly different when only tumour specimens (excluding infectious/ inflammatory specimens, which were mostly softtissue lesions) were considered and when categorised by tumour types ( Table 5 ).
The accuracy of CT-guided CNB for specific diagnosis of benign soft-tissue tumours (66.7%) as well as infectious and inflammatory lesions (51.7%) was relatively low ( Table 5 ). Of 3 benign soft-tissue tumours diagnosed by CT-guided CNB, one pigmented-villonodular synovitis specimen was initially reported to be only a histiocytic lesion with round cells and brown pigment. Of the 31 infectious/inflammatory lesions diagnosed by CTguided CNB, 15 were soft-tissue tuberculosis, 7 of which had evidence of granulomatous inflammation with a central necrotic area, whereas 8 had no central necrosis. All tuberculous lesions were diagnosed using acid-fast bacilli stains and polymerase chain reaction before treatment was commenced.
discussion
CT-or ultrasonography-guided CNB increases diagnostic accuracy and safety by confirming the targeted areas and avoiding damage to neurovascular bundles, particularly when the lesions are deepseated, located in the pelvis, spine, sacrum or scapula, or close to important structures such as neurovascular bundles. 5, 6 The accuracy of imaged-guided CNB for musculoskeletal lesions has been 80% to 97%. [5] [6] [7] [13] [14] [15] However, distinguishing benign lipomas from well-differentiated liposarcomas through biopsy is difficult, because the malignant component may be deep-seated or involved only a small area. Thus, using magnetic resonance imaging to establish the diagnosis is more reliable. When in doubt, biopsy is indicated in lipomatous lesions with more heterogeneity, with gadolinium enhancement or suspected intermediateor high-grade liposarcomas. CT-guided CNB enables visualising the exact location for sampling, especially when the lesion was small or deep.
In the current study, the accuracy of CT-guided CNB in distinguishing benign from malignant lesions and low-from high-grade sarcomas was high, because decision was made after careful discussion between the orthopaedic oncologist, pathologist, and radiologist. 10 In addition, we tried not to biopsy lesions that appeared to be low-grade lipomatous tumours, low-grade cartilaginous tumours, or myxoid, as they are difficult to interpret histologically. 3 Table 4 Accuracy of computed tomography-guided core needle biopsy (CT-guided CNB) and incisional biopsy for bone versus softtissue lesions Table 5 Accuracy of computed tomography-guided core needle biopsy (CT-guided CNB) and incisional biopsy in terms of lesion type lipomatous tumour, well-differentiated liposarcoma, or low-grade chondrosarcoma can be safely treated by marginal resection without biopsy 17, 18 or extended intralesional curettage, 19, 20 as the risk of recurrence is low. Nonetheless, in indeterminate lesions, biopsy is still recommended. Moreover, the number of soft-tissue tumours was fewer than that of bone tumours; soft-tissue tumours such as schwannoma, synovial sarcoma, and angiosarcoma may consist of heterogenic cells or myxoid areas, for which it is difficult to achieve a correct diagnosis or grading. 13 The accuracy of both biopsies for specific diagnosis of bone metastasis and myeloma was relatively high, which was consistent with findings from other studies, 7,10-12 as their homogeneous nature enabled the biopsy to contain diagnostic tumour cells. 13 The accuracy of CT-guided CNB for specific diagnosis of infection/inflammation was relatively low, which was also consistent with studies reporting rates of 50% 6 and 78%. 7 CT-guided CNB is an accurate procedure for diagnosing musculoskeletal lesions. It can be easily repeated without major morbidity. Its complication rates are trivial, 7, 13, 21 and the repeated biopsy rate is similar to that after incisional biopsy. CT-guided CNB when performed by a multidisciplinary team trained in the musculoskeletal tumour field should be considered as the first-line biopsy for diagnosing musculoskeletal lesions.
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